Recommendations and opinions for the use of point-of-care testing for hospitals and primary care: summary of a 1999 symposium

Hicks, Jocelyn M.; Haeckel, Rainer; Price, Christopher P.; Lewandrowski, Kent; Wu, Alan H.B.

doi:10.1016/s0009-8981(00)00400-9

Cited by 49 publications

(25 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The difference between the TAT at the POCT and in the clinical laboratory has been one of the most frequently discussed issues in studies on POCT [27][28][29][30]. The TAT from collecting the specimen to receiving the blood gas analysis report in the doctor's office was considerably less than the corresponding time for the emergency laboratory (1 min vs. 79 min).…”

Section: Difference Between Poct and Emergency Laboratory Blood Gas Amentioning

confidence: 99%

See 1 more Smart Citation

Clinical, operational and economic outcomes of point-of-care blood gas analysis in COPD patients

Oliver

Buño

Álvarez-Sala

et al. 2015

Clinical Biochemistry

View full text Add to dashboard Cite

Section: Difference Between Poct and Emergency Laboratory Blood Gas Amentioning

confidence: 99%

“…The majority of studies that address the economic outcomes only consider the cost per measurement in a POCT unit compared with a clinical laboratory [30]. In this study, each blood gas measurement costs 3.47€ in the doctor's office and 1.35€ (2.5 times less) in the emergency laboratory.…”

Section: Overall Cost Per Process Of Patient Carementioning

confidence: 99%

Clinical, operational and economic outcomes of point-of-care blood gas analysis in COPD patients

Oliver

Buño

Álvarez-Sala

et al. 2015

Clinical Biochemistry

View full text Add to dashboard Cite

“…Glycated hemoglobin (HbA1c) is a well-established marker for measuring the long-term effect of elevated blood glucose, but levels of glycated human serum albumin (gHSA) are a reliable intermediate glycemic indicator and is a more accurate indicator of glycation in a number of situations including patients with gestational diabetes [14,15], diabetic hemodialysis patients [16,17], and in HIV-infected patients undergoing aggressive antiretroviral therapy [18]. A rapid test for gHSA as a monthly indicator of glycation could bring about a substantial healthcare cost savings as well as an increase in patient compliance [11].…”

Section: Introductionmentioning

confidence: 99%

Evaluation of Aromatic Boronic Acids as Ligands for Measuring Diabetes Markers on Carbon Nanotube Field-Effect Transistors

Stefansson¹,

Stefansson²,

Chung³

et al. 2012

Journal of Nanotechnology

View full text Add to dashboard Cite

Biomolecular detections performed on carbon nanotube field-effect transistors (CNT-FETs) frequently use reactive pyrenes as an anchor to tether bioactive ligands to the hydrophobic nanotubes. In this paper, we explore the possibility of directly using bioactive aromatic compounds themselves as CNT-FET ligands. This would be an efficient way to functionalize CNT-FETs since many aromatic compounds bind avidly to nanotubes, and it would also ensure that ligand-binding molecules would be brought in close proximity to the nanotubes. Using a model system consisting of pyrene, phenanthrene, naphthalene, or phenyl boronic acids immobilized on CNT-FET wafers, we show that all are able to bind glycated human serum albumin (gHSA), which is an important diabetes marker. Pyrene boronic acid proved to bind CNTs with the greatest apparent affinity as measured by gHSA impedance. Interestingly, gHSA CNT-FET signal intensity, which is proportional to amount of protein bound, remained essentially unchanged for all the boronic acids tested.

show abstract

“…Their increased use has led to concerns regarding inappropriate use by untrained staff, and guidelines have been published on the management of POCT in general and particularly for haematology [3,4]. Among the recommendations are supervision by the local pathology laboratory, and enrolment in a quality control programme.…”

Section: Discussionmentioning

confidence: 99%

“…Provided that adequate training is undertaken for users and quality control is discussed with the local hematology laboratory [3,4], a BGA may be a valid alternative to the traditional HA in the rapid assessment of Hb.…”

Section: Discussionmentioning

confidence: 99%

External quality assessment in the measurement of haemoglobin by blood gas analysers in Belgium

Blerk¹,

Coucke²,

Châtelain³

et al. 2007

Scandinavian Journal of Clinical and Laboratory Investigation

View full text Add to dashboard Cite

For the BGAs from Bayer, Radiometer and Roche, interlaboratory variation ranged from 0.6 % to 4.1 %, indicating good precision and close agreement between centres. A significant negative bias observed on the GEM Premier 3000 using the EDTA anticoagulated blood samples did not appear to be present in fresh heparinized whole blood samples. There was no significant difference in imprecision and bias between Hb measurements on BGA situated in and outside the central laboratory.

show abstract

Recommendations and opinions for the use of point-of-care testing for hospitals and primary care: summary of a 1999 symposium

Cited by 49 publications

References 39 publications

Clinical, operational and economic outcomes of point-of-care blood gas analysis in COPD patients

Clinical, operational and economic outcomes of point-of-care blood gas analysis in COPD patients

Evaluation of Aromatic Boronic Acids as Ligands for Measuring Diabetes Markers on Carbon Nanotube Field-Effect Transistors

External quality assessment in the measurement of haemoglobin by blood gas analysers in Belgium

Contact Info

Product

Resources

About